News | Radiation Therapy | March 07, 2016

New radiosurgery system enables greater precision in the frameless treatment of brain tumors

Elekta, Leksell Gamma Knife Icon, stereotactic radiosurgery, SRS system, first U.S. patient, Sutter Medical Center Sacramento

March 7, 2016 — Elekta announced that its Leksell Gamma Knife Icon stereotactic radiosurgery (SRS) system was used for the first time in the United States to treat a metastatic brain tumor. The procedure was conducted on March 1 at Sutter Medical Center, Sacramento Gamma Knife Center in Sacramento, Calif.

The patient, a 52-year-old male from El Dorado Hills, Calif., had previously undergone successful treatment for primary melanoma and for melanoma metastases to his lung. The patient's treatment was planned and guided using a frameless approach. The frameless mask solution is one of several new features of Icon and is integrated with a novel high definition motion management. The system provides accuracy similar to that of frame-based SRS systems while minimizing dose to normal tissue.

"Increasing the precision of frameless cranial SRS is essential for effectively targeting tumor tissue while protecting healthy brain tissue from damage," said Samuel Ciricillo, M.D., medical director of adult and pediatric neurosurgery at Sutter Neuroscience Institute. "The new Gamma Knife system, Icon, now provides the most accurate motion tracking during treatment. Additionally, with Gamma Knife there is a two- to four-fold improvement in sparing normal brain tissue compared to other linear accelerator platforms. These features allow for greater potential to protect patient quality of life both during treatment and after recovery."

Icon is the latest advance in Elekta's Gamma Knife radiosurgery. The system will make cranial SRS available to more patients and improve the efficacy of cranial SRS with fewer side effects. Icon also provides the flexibility for single dose administration or multiple treatment sessions over time, which enables treatment of larger tumor volumes, targets close to critical brain structures, and new or recurring brain metastases.  

At the time of SRS, pre-treatment magnetic resonance imaging (MRI) and cone beam computed tomography (CBCT) images are aligned to identify precise coordinates for radiation targeting within the brain. This technology is especially important for patients who undergo multiple treatment sessions. Because the CBCT images are based on fixed structures within the brain, they ensure that dosage and delivery area are calculated correctly for each session, even if the patient's head is in a slightly different position from one treatment session to another.

Ciricillo worked with Sutter Medical Center radiation oncologist Harvey Wolkov, M.D., and physicist Stanley Skubic, Ph.D., on the procedure. They are founding members of the team that started the Sutter Gamma Knife program in 1998.

For more information: www.elekta.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now